SA
IBRX icon

Sanctuary Advisors’s ImmunityBio IBRX Stock Holding History

Sanctuary Advisors’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$280K Buy
31,986
+2,402
+8% +$18.2K ﹤0.01% 2371
2026
Q1 		$227K Buy
29,584
+37
+0.1% +$253 ﹤0.01% 2283
2025
Q4 		$58.5K Buy
29,547
+1,918
+7% +$4.34K ﹤0.01% 2378
2025
Q3 		$68K Sell
27,629
-2,745
-9% -$7.07K ﹤0.01% 2371
2025
Q2 		$80.2K Sell
30,374
-708
-2% -$1.9K ﹤0.01% 2284
2025
Q1 		$93.6K Buy
31,082
+898
+3% +$2.72K ﹤0.01% 2117
2024
Q4 		$105K Buy
30,184
+1,000
+3% +$4.17K ﹤0.01% 2313
2024
Q3 		$149K Sell
29,184
-7,656
-21% -$35.4K ﹤0.01% 2273
2024
Q2 		$271K Buy
+36,840
New +$243K ﹤0.01% 2010

Other funds holding IBRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sanctuary Advisors's IBRX Position: Q2 2026 in Review

Sanctuary Advisors increased its ImmunityBio (IBRX) stake by 8.1% in Q2 2026, buying an estimated $18.2K and bringing the position to 31,986 shares worth $280K. The position accounts for ﹤0.01% of the portfolio, ranked #2371.

Sanctuary Advisors first reported a position in IBRX in Q2 2024 and has held it in 9 quarters since. 404 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

  • Sanctuary Advisors held 31,986 shares of ImmunityBio worth $280K as of Q2 2026.
  • Sanctuary Advisors bought 2,402 ImmunityBio shares in Q2 2026, an estimated $18.2K.
  • ImmunityBio made up ﹤0.01% of Sanctuary Advisors's portfolio in Q2 2026, its #2371 holding.
  • Sanctuary Advisors first reported a position in ImmunityBio in Q2 2024 and has held it in 9 quarters since.
  • 404 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.